This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EDWARD F. CORSON, M.D.; HENRY B. DECKER, M.D.; THOMAS L. WILLIAMS, Ph.C., B.S.

Arch Derm Syphilol. 1940;42(5):868-873.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Preparations of arsenic or bismuth are at present the most effective and dependable therapeutic agents for the treatment of syphilis. Therapy by these two drugs is continuously or alternately employed with the object of inflicting the maximum damage to the causative organism with the minimum injury to the body tissues. It is necessary in the case of bismuth to insure a fairly continuous supply of the medicament for effectively maintaining adequate therapy. This is accomplished by regular administration of additional quantities of the drug. Bismuth therapy by this approach leads to retention of the drug in the tissues. Relatively large quantities of retained bismuth are stored in the body when the preparation is employed over a long period in patients resisting a reasonable amount of medication.

It is possible that untoward effects may result from this storage. Cormia¹ called attention to a depressing influence produced by bismuth therapy and . . . [Full Text PDF of this Article]

Author Affiliations
PHILADELPHIA; CAMDEN, N. J.; PHILADELPHIA

Footnotes
Read at the Sixty-Third Meeting of the American Dermatological Association, Inc., Colorado Springs, Colo., May 30, 1940.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?